SCHEMBL5720239

SCHEMBL5720239

ClC(Cl)(Cl)c1cccc2nccnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
MAPT P10636 4/20 0.48
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
USP2 O75604 1/20 0.48
POLB P06746 1/20 0.48
HSD17B10 Q99714 1/20 0.33
CISD1 Q9NZ45 1/20 0.33
NR4A2 P43354 1/20 0.32
PKM P14618 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
HDAC6 Q9UBN7 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
GAA P10253 2/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720490 0.81 KDM4E (0.50) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL10840576 0.79 MAPT (0.48) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL10250183 0.79 ALDH1A1 (0.48) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL20287857 0.76 KDM4E (0.46) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL198303 0.76 MAPT (0.54) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL30131535 0.75 KDM4E (0.54) KDM4EMAPTMEN1KMT2ATSHR
SCHEMBL11846063 0.75 KDM4E (0.54) KDM4EMAPTMEN1KMT2ATSHR
Methane SCHEMBL28257008 0.74 MAPT (0.52) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL27991410 0.73 MAPT (0.52) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL21846090 0.73 KDM4E (0.43) KDM4EMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 US disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 US disclosed
EP-1072576-B1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2006-08-02 EP disclosed
US-6417361-B1 HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND MITSUI CHEMICALS, INC. (JP) 2002-07-09 US disclosed
CN-1294568-A Fluorinating agent, process for producing same, and use thereof MITSUI CHEMICALS INC (JP) 2001-05-09 CN disclosed
EP-1072576-A1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2001-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 KDM4E 2254/4885MAPT 729/4885ALDH1A1 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.